Kimberly-Clark Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/10/2026)
| Balance Sheet | Total Assets | 17,098,000,000.00 | ROE | 8.72 % |
| Balance Sheet | Total Equity | 1,502,000,000.00 | ROA | 11.73 % |
| Cashflow | Capital Expenditures | -1,138,000,000.00 | P/FCF | 20.20 |
| Cashflow | Free Cash Flow | 1,639,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 2,777,000,000.00 | P/CF | 11.92 |
| Income | Earnings per Share (diluted) | 6.07 | Div. Yield | 5.07 % |
| Income | Net Income | 2,021,000,000.00 | P/E | 16.38 |
| Income | Shares Outstanding | 333,100,000.00 | P/B | 22.05 |
| Income | Total Revenue | 16,447,000,000.00 | P/S | 1.92 |
Ratios calculated on: 10/14/2026
Company Description
Kimberly-Clark Corporation (Kimberly Clark) is a global company focused on the world in essentials for a better life through product innovation and building its personal care, consumer tissue, K C professional and health care brands. The Company is principally engaged in the manufacturing and marketing of a wide ranges of products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens and absorbency. Its operating segments include Personal Care , Consumer Tissue K C Professional and HealthCare. The Company operates and markets its products globally in Asia, Latin America, Eastern Europe, the Middle East and Africa, with a particular emphasis in China, Russia and Latin America. In April 2013, it announced the acquisition of the anesthesia business of Life-Tech, Inc.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.kimberly-clark.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more